USD 16.18
(-4.94%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 673.3 Million USD | -17.89% |
2022 | 820 Million USD | 10.13% |
2021 | 744.6 Million USD | 4.17% |
2020 | 714.8 Million USD | 2.47% |
2019 | 697.6 Million USD | 6.94% |
2018 | 652.3 Million USD | 6.65% |
2017 | 611.6 Million USD | -61.59% |
2016 | 1.59 Billion USD | 1.14% |
2015 | 1.57 Billion USD | -5.84% |
2014 | 1.67 Billion USD | -0.32% |
2013 | 1.67 Billion USD | -0.39% |
2012 | 1.68 Billion USD | 1.45% |
2011 | 1.65 Billion USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 171.7 Million USD | 3.37% |
2024 Q3 | 170.4 Million USD | -0.76% |
2024 Q1 | 166.1 Million USD | -4.15% |
2023 Q3 | 171.3 Million USD | 1.12% |
2023 Q2 | 169.4 Million USD | -11.63% |
2023 Q1 | 191.7 Million USD | -11.86% |
2023 FY | 673.3 Million USD | -17.89% |
2023 Q4 | 173.3 Million USD | 1.17% |
2022 FY | 820 Million USD | 10.13% |
2022 Q4 | 217.5 Million USD | 7.62% |
2022 Q3 | 202.1 Million USD | -0.44% |
2022 Q2 | 203 Million USD | 2.84% |
2022 Q1 | 197.4 Million USD | 2.07% |
2021 Q2 | 186.4 Million USD | 3.15% |
2021 Q4 | 193.4 Million USD | 5.05% |
2021 FY | 744.6 Million USD | 4.17% |
2021 Q3 | 184.1 Million USD | -1.23% |
2021 Q1 | 180.7 Million USD | -2.32% |
2020 Q2 | 163.7 Million USD | -9.26% |
2020 Q1 | 180.4 Million USD | -4.95% |
2020 Q3 | 185.7 Million USD | 13.44% |
2020 FY | 714.8 Million USD | 2.47% |
2020 Q4 | 185 Million USD | -0.38% |
2019 Q4 | 189.8 Million USD | 10.74% |
2019 Q2 | 172.2 Million USD | 4.87% |
2019 Q3 | 171.4 Million USD | -0.46% |
2019 Q1 | 164.2 Million USD | -3.35% |
2019 FY | 697.6 Million USD | 6.94% |
2018 FY | 652.3 Million USD | 6.65% |
2018 Q4 | 169.9 Million USD | 2.91% |
2018 Q3 | 165.1 Million USD | 2.61% |
2018 Q2 | 160.9 Million USD | 2.88% |
2018 Q1 | 156.4 Million USD | 126.75% |
2017 Q3 | 401.4 Million USD | 0.55% |
2017 FY | 611.6 Million USD | -61.59% |
2017 Q4 | -584.6 Million USD | -245.64% |
2017 Q2 | 399.2 Million USD | 0.91% |
2017 Q1 | 395.6 Million USD | -3.51% |
2016 Q3 | 397.5 Million USD | -0.63% |
2016 FY | 1.59 Billion USD | 1.14% |
2016 Q4 | 410 Million USD | 3.14% |
2016 Q2 | 400 Million USD | 3.95% |
2016 Q1 | 384.8 Million USD | -4.14% |
2015 FY | 1.57 Billion USD | -5.84% |
2015 Q4 | 401.4 Million USD | 3.06% |
2015 Q3 | 389.5 Million USD | 0.05% |
2015 Q2 | 389.3 Million USD | -1.24% |
2015 Q1 | 394.2 Million USD | -10.29% |
2014 Q1 | 410.7 Million USD | -4.78% |
2014 FY | 1.67 Billion USD | -0.32% |
2014 Q2 | 413.5 Million USD | 0.68% |
2014 Q4 | 439.4 Million USD | 7.56% |
2014 Q3 | 408.5 Million USD | -1.21% |
2013 Q2 | 415.9 Million USD | 1.24% |
2013 Q4 | 431.3 Million USD | 2.81% |
2013 Q1 | 410.8 Million USD | 0.0% |
2013 FY | 1.67 Billion USD | -0.39% |
2013 Q3 | 419.5 Million USD | 0.87% |
2012 FY | 1.68 Billion USD | 1.45% |
2011 FY | 1.65 Billion USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Abbott Laboratories | 40.1 Billion USD | 98.321% |
Allurion Technologies Inc. | 53.46 Million USD | -1159.281% |
Artivion, Inc. | 354 Million USD | -90.196% |
Butterfly Network, Inc. | 65.9 Million USD | -921.7% |
Butterfly Network, Inc. | 65.9 Million USD | -921.7% |
Bio-Rad Laboratories, Inc. | 2.67 Billion USD | 74.795% |
Boston Scientific Corporation | 14.24 Billion USD | 95.272% |
Perspective Therapeutics, Inc. | 7.1 Million USD | -9377.759% |
CONMED Corporation | 1.24 Billion USD | 45.743% |
Edwards Lifesciences Corporation | 6 Billion USD | 88.787% |
Paragon 28, Inc. | 216.38 Million USD | -211.153% |
Glaukos Corporation | 314.71 Million USD | -113.942% |
Globus Medical, Inc. | 1.56 Billion USD | 57.073% |
Inspire Medical Systems, Inc. | 624.79 Million USD | -7.763% |
Integer Holdings Corporation | 1.59 Billion USD | 57.831% |
Medtronic plc | 32.36 Billion USD | 97.92% |
Nevro Corp. | 425.17 Million USD | -58.359% |
Owlet, Inc. | 54.01 Million USD | -1146.621% |
Penumbra, Inc. | 1.05 Billion USD | 36.392% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 5.54 Billion USD | 87.866% |
Sonendo, Inc. | 43.86 Million USD | -1434.937% |
STERIS plc | 5.13 Billion USD | 86.897% |
Stryker Corporation | 20.49 Billion USD | 96.715% |
Vapotherm, Inc. | 68.66 Million USD | -880.501% |
Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 90.894% |